Skip to main content
. Author manuscript; available in PMC: 2012 Jun 7.
Published in final edited form as: Infect Genet Evol. 2011 Aug 22;12(4):671–677. doi: 10.1016/j.meegid.2011.08.011

Table 3.

Description of the MDR M. tuberculosis complex strains among smear-positive tuberculosis patients in Cross River State, Nigeria*.

ID
strain		 Year of
isolation		 SIT (Clade)
Spoligotype Description		 12-loci MIRU
Pattern (MIT)** 		Sex
(Age
group)		 HIV serology,
Drug resistance***
123TH 2009 graphic file with name nihms378143t11.jpg 223315153321 (266) F (25–34) HIV-negative, SIRE
124TH 2009 graphic file with name nihms378143t12.jpg 223315153321 (266) M (25–34) HIV Unk, SIRE
125TH 2009 graphic file with name nihms378143t13.jpg 223315153321 (266) M (15–24) HIV-negative, SIRE
126TH 2009 graphic file with name nihms378143t14.jpg 223315153321 (266) M (35–44) HIV Unk, SIRE
127TH 2009 graphic file with name nihms378143t15.jpg 22222514332X (orphan) F (25–34) HIV-positive, SIRE
64IDH 2008 graphic file with name nihms378143t16.jpg No result M (25–34) HIV Unk, SIRE
*

Drug-susceptibility testing (DST) was done for 58/81 clinical isolates; MDR strains correspond to 10.4% (n = 6/58) of strains with known DST.

**

Among MIRU patterns shown, the letter “X” denotes loci that could not be amplified.

***

Abbreviations: S, Streptomycin; I, Isoniazid; R, Rifampicin; E, Ethambutol; Unk, unknown.